-
公开(公告)号：US12180551B2
公开(公告)日：2024-12-31
申请号：US17966689
申请日：2022-10-14
Applicant: Myriad Genetics, Inc.
Inventor： Alexander Gutin , Julia Reid , Ralf Kronenwett , Marsel Scheer
Abstract: Provided herein are methods for predicting chemotherapy benefit. The invention predicts chemotherapy benefit based on the expression analysis of biomarkers, e.g., RNA biomarker transcription analysis, taken from a tumor sample. The biomarker expression data can be combined with clinical variables, e.g., tumor size and nodal status, to generate a profile that predicts the benefit of including chemotherapy as a treatment decision.
-
公开(公告)号：US20230116885A1
公开(公告)日：2023-04-13
申请号：US17966689
申请日：2022-10-14
Applicant: Myriad Genetics, Inc.
Inventor： Alexander Gutin , Julia Reid , Ralf Kronenwett , Marsel Scheer
Abstract: Provided herein are methods for predicting chemotherapy benefit. The invention predicts chemotherapy benefit based on the expression analysis of biomarkers, e.g., RNA biomarker transcription analysis, taken from a tumor sample. The biomarker expression data can be combined with clinical variables, e.g., tumor size and nodal status, to generate a profile that predicts the benefit of including chemotherapy as a treatment decision.
-
公开(公告)号：US11505832B2
公开(公告)日：2022-11-22
申请号：US16809338
申请日：2020-03-04
Applicant: MYRIAD GENETICS, INC.
Inventor： Alexander Gutin , Julia Reid , Ralf Kronenwett , Marsel Scheer
Abstract: Provided herein are methods for predicting chemotherapy benefit. The invention predicts chemotherapy benefit based on the expression analysis of biomarkers, e.g., RNA biomarker transcription analysis, taken from a tumor sample. The biomarker expression data can be combined with clinical variables, e.g., tumor size and nodal status, to generate a profile that predicts the benefit of including chemotherapy as a treatment decision.
-
-
Search Results
3
records
(took 0.026 seconds)
